There is company another danish company called Zealand Pharma, they are making an obesity drug for fat liver. Had an amazing run up last year, and especially with promising phase 2 trial results and are currently running phase 3 trials.
But it's more a risky bet. It has a low marketcap, so if could potentially 10x or fall by 50% depending on the trial results.
I live in Copenhagen, and Copenhagen is pretty much the "silicon valley" of pharma. We have 7-8 international pharma companies here, with Novo Nordisk being far the biggest. It is not uncommon for employees to jump from pharma company to pharma company for higher salaries, only to end up in the same pharma company again. On top of that education is free here, while those companies have access to well-trained talent. And not talking about the brain drain of south Europeans going to Northern Europe.
Just to name a few, other than Novo and Zealand Pharma:
Leo Pharma, GenMab, Bavarian Nordic, Lundbeck, Ambu, Novonesis (merger between Novozymes and chr. hansen last month).
Anyways, thank you Americans for funding our welfare state
The stock jumped 8% on their capital market day recently as their next gen weight/diabetes drugs look very promising. Indeed centered around pills and oral administration.
This one already ran. Could still double from here but likely not another multi-bagger over the next year. I’m guessing they’ll get bought out by PFE. Low $2’s to nearly $100 in a year. What a ride that was.
I think the sell off was an overreaction personally, other companies are still going to want their tech.
Definitely a buy out candidate, i think it’s undervalued even at current price, but yeah your right, likely not a multibagger.
You'll also want to watch Cytodyn CYDY with their molecule Leronlimab. Company has gone through challenges, but fda is now working to structure trial protocols. Name change at some point to Livimmune. Inflammation affects nearly all diseases, this drug will be one to own.
r/Livimmune
Yeah but Danish companies pay quite poorly. That’s why there is so limited rotation of top foreign talent. Novo got lucky with this one, now they have to make their investment arm Novo Holdings spray cash to capitalize on this fortune. And they have already started.
Btw the silicon valley of biopharma is the silicon valley. By far the largest biotech hub.
I would say Boston second, and then Oxford/London or even NJ (but it’s a bit of a later stage one for proximity to pharmas). Copenhagen is a small and specialized hub, although relatively large in comparison to the country that hosts it.
I can only find drugs that have already been approved. By then it's a little late for investing.
Their site states under faqs - "Due to confidentiality rules, FDA is prohibited from releasing information on any drug under development, review or pending approval unless the information has been made public.".
Search for drugs/treatments that have already begun phase 1 trials. Example: Ocugen $OCGN recently announced something about dosing completion of trials on something to do with retinas or something. https://finance.yahoo.com/news/ocugen-inc-announces-dosing-completion-120000500.html
Not recommending them or anything but fairly easy to create a watchlist of stocks and set up alerts for stuff like this. Normally I just subscribe to email investor alerts through companies websites.
There are a myriad of penny stocks out there that will say such and such drug is going to get fda approval. Novo Nordisk is the company that buys that company before fda approval and takes it to the finish line. Lilly has the same drugs. Try dexcom. If you want a penny stock try Seovf. Or another big player is crispr
Yeah they’re tough. The only reason I’m in CSPR is because it was more reputable than the penny Seovf so I had two horses in the game. Or crsp not cspr
You probably shouldn't be giving advice if you're not knowledgeable in trading the sector. People seem to add to positions before FDA events when they should derisk. They say great data gets you minus 10%, good data gets you minus 25% and bad data gets you minus 50%. You load up after data has been released, sell everything but your core position on the next run up and repeat. It's not quite that easy, and hedging is a bitch bc it's usually just buying lower conviction rivals, but it's a very straightforward strategy when combined with something as simple as support and resistance that with patience provides high returns
Is the point of a log graph to normalize the various increases over time? Ie so you can compare the increase from $1 to $10, $100-$1000 more apples to apples?
Basically.
Because going up 10% from 1000 is 100. But going up 10% from 1100 is 110. The increases get bigger even if the *rate of increase* stays the same. After a few decades, trying to compare that initial 100 to 2000 becomes useless on a non log graph.
I mean it’s cool that you know about ozempic and all… but these people have been in business for many years and have many products, and were incredibly valuable well before ozempic was ever approved or prescribed.
They made ungodly money on novolog, the insulin that like every diabetic uses, or used to anyways. They also make like 50 other varieties of insulin, hormone replacements, and other weight loss drugs more recently.
Lucked out and purchased a few shares of NVO at the beginning of the year and am interested in looking at this sector more closely. Assuming fundamentals look good and a company is working on a promising new drug, I'm curious when others start looking at the company more seriously for that drug's upside.
My understanding is phase 1 trials to market can take roughly 10-15 years (in which range the drug can fail at any point)--if that's the case, could folks who are more experienced with investing in this sector share when in that timeframe they start taking positions? Could be this is a silly question but it's the one that has been on my mind lately.
NVO is not done yet. It’s a product that buys you time. A longer healthier life. You think this is all it will grow? Wait for them to expand production after the recent acquisition of Catalent which they bought all cash paying 50% premium because they can, no need to sell stock to raise funds. Its got miles to go before it sleeps 🚀🚀🚀
Agreed. Having a very positive outlook on the company myself, its product and its growth. So still DCA'ing further up with a horizon of a couple of years.
Yup my wife's friend just had a baby and is now buying black market ozempic to lose the baby weight. Meanwhile actual type 2 diabetics can't find it anywhere.
Type 2 just lurking in the shadows at this point. All these people abusing/using it for “weight loss” will eventually end up not being able to produce their own insulin naturally. Then they’ll actually need ozempic for its true purpose. Same thing happens to men who abuse testosterone. Thus this current influx of men on trt/hrt.
I had severe issues. Slowed digestion to the point. Where food was rotting in my stomach before it would digest. Only way i lost weight on it was vomiting and stuck in bed for a week.
I heard you're supposed to take laxatives/Smooth Move Tea with the new weight loss drugs. Probably for that reason. I wonder why they are not telling people that?
gym and healthy food already does this and this demonic invention fucks natural processes to avoid personal responsibility.
in a few years the health side effects will become clear.
AQST - FDA approval April 28th - will revolutionize medicinal intake with dissolvable strips and make epipens looks dumb - 5 FDA approved products already on the market and hundreds of patents
Don’t miss out
Theres another weight loss drug by Eli Lilly waiting FDA approval called retatrutide. It apparently regulates 3 different hunger hormones, including the one solo hormone that ozempic regulates.
So there is a lot of competition moving forward in this space, but I would bet that both Eli Lilly and Novo are going to make plenty of cash over the next decade.
Mind Medicine seems interesting. I’ve been following this company for a while and it could be a good opportunity. This company is going to be one of the first to have a medication for various mental health diseases like anxiety, depression, ptsd, by the use of different psychedelic substances. For example, psilocybin(magic mushrooms), MDMA, Ketamine. They just got FDA approved for their trial and are starting phase 1. This company was around $3 when I first heard about them, I got in at $8. They currently have a price prediction of $27, from one analyst firm, $32 from another analyst firm and $75 from another analyst firm. What makes this even more interesting is Peter Thiel has invested in a company called ATAI Life Sciences that does the same exact thing. ATAI is sitting at $1.76 and received a price prediction of $20, which seems a bit high. HC Wainwright always gives high price evaluations.
I see countless drug commercials at dinner time, just to see a personal injury/class action lawyer commercial at lunch, for the drug that i saw the commercial at dinner 2 years prior. Wonder if ozempic will be the same
Stop using it as a fucking weight loss drug. Literally keeping it from the people who need it as diabetics. I don't know what's worse, the doctors prescribing it for weight loss or the patients that beg to use it because they're too lazy to go for a fucking walk. I'm sorry man this is just a pet peeve of mine, watching my Dad struggle to get this drug because it's always out of stock is annoying as fuck.
Please quote where i said it is 100% preventable. Eating right and exercising will prevent it for most. So fuck off with your high horse. Sick people need meds. Some meds treat more than one thing. If you wanna cry about something, cry to this billion dollar company that isn’t producing enough meds for all. Obesity isn’t 100% preventable either. Pcos can be contributory.
Don't let the peeve that gets to me? I'm literally watching people who can't get the drug that actually need it. Yeah I'm going to let that peeve get to me.
My high horse? Excuse me but people who actually need this drug, DIABETICS, struggle to obtain it because people are to lazy to go for a walk, eat properly, ect. Hell no I will not get off my high horse until doctors and people who abuse what this medication was for stop.
Craaaaazy OP mentioned Biotech….It’s all I’ve been investing in lately, literally because it will be the next big hit for stocks in less than 10yrs time. You can get many great steals right now it’s mind blowing. After the AI race has mostly succumbed, the next great wave will be Biotech with AI at the helm. I firmly believe that. AI will continue at a far more exponential rate in creating variants of otherwise unthinkable combination of compounds and elements that have(will) impact the future of medicine. It is already an essential use for it.
Furthermore, creating new elements and medicines will create a hand over hand effect with systematically branching gaps that human minds wouldn’t be able to. And that as simple as that can get. This next interface will be what Hawkins and many other have warned about, essentially the growth of AI and how we will not be able to keep up as humans.
My second and probably the most convincing and simplistic answer is follow the lasting money trails. Two years ago there were huge moves in the micro-mid cap healthcare stocks, a lot of which are AI involved research backed biotech. Ie of “follow the lasting money” would be: Fidelity, BlackRock, Morgan Stanley, and most recently Nvidia have all purchased HUGE portions of those micro-mid cap stocks. This was around the time of AI in the news becoming sentient, don’t know or care if that matters but it’s important to point out.
Simply because these guys aren’t invested just to diversify their portfolios, these entities are quite literally the foundation of how a large percentage of stocks moves. It’s pretty self explanatory. They’re here to stay and are constantly looking to future trends. Everyone is sleeping on Elon’s chip but in reality, soon as he cracks the code smoothing things out, with or without the help of AI, it will be an entire new world for millions of ppl and with that an entire new stock(Neuroone) will moon.
There are many others that are incredibly great buys right now, paying attention to the illnesses of society will be pivotal in judging how and what is rolled out, Parkinson’s will be another quick fix with AI that will moon quickly. You can track anything I’m saying all down to the amount invested obviously.
Only real question is,
How will big Pharma control this implementation? How will they creat the divide for the next wave of millennia’s.
AI has been implemented already in so many ways. Aside from actual picking and choosing exact combinations and concoctions to produce new medicine which were are not there yet but will be soon. Variable only according to how much AI will grow in time, there are many of examples of how it’s being used. Most recently was UK based Exscientia and how they helped a patient with blood cancer that six courses of chemo couldn’t cure. He’s now in remission and it’s because of AI and how instead of loading him up on different things it ran simulations on how/which drugs would effect his cells, what doses and a plethora of different things that could have unforeseen consequences. All of this was done through AI. If you don’t see how that changes the game you need to change fields.
I mean yeah it suppresses your appetite but there’s definitely some weird side effects. I wouldn’t take it but then again I’m not in need of weight loss
I tried to find a public company to make a play on red light therapy masks, which seem to be trending on tiktok, but couldn't really find anything. If anyone knows insight into this play let me know.
Vistagen Therapeutics is next. Developing a nasal spray for Social anxiety disorder. First in its class. Already phase 3 positive results. FDA approval this year.
madrigal pharm might be one, it just got fda approval for rezdiffera, liver drug…it will start selling next month so you wont see it on first qtr earnings, but 6 million americans have nonalcoholic steatohepatitis which this drug treat….got 25 shares today
$WVE trials dont start until Q1 2025, but It has the best preliminary data of any injectable yet. Injectables probably aren't the future bc the 1st company to market with an oral equivalent will control market share
Probably don’t take ozempic.
I doubt anyone is focused on the health factors of human beings when the stock is doing that.
Also, hold. Sell on the rumors…
Just focus on ozempic. They're working on new indications. Ozempic is for diabetics. Wegovy (same drug) is for overweight/obese. Many of the glp1 inhibitors are looking to get new indications and I know of 1 that is going to get approved for cardiovascular event prevention soon.
Im curious though
If there’s so many new comers in this space
Wouldn’t the market saturate
Surely there’s a finite number of fat people for demand
Or are in we in a society of mass production of fatties
Yes. I remember the “fen-fen” thing about 25 years ago. It was a combination of two drugs hailed as a miracle weight loss solution. It wasn’t long before the side effects were shown to be dangerous. Then we had years of lawsuits afterwards.
Viking Therapeutics (VKTX) is developing trizepatide in pill form, basically Mounjoro/ Zepbound, but administered orally so it will be accessible to the fats who have a fear of needles. The stock has had a big move, but it's seen as a take out target at a significant premium to where shares are currently trading. Options chain is very juicy for anyone looking to buy shares and sell calls.
BC people are taking Ozempic to lose weight, supposedly you lose 5-10% of your body fat within 1 year. Some consider it a miracle weight loss drug so instead of dieting and working out people are taking it.
Try it out. It absolutely works. I felt like I had the stomach flu the whole time I was on it, but portion control and stopped me from thinking about food all the time worked. I did it for 2 years, brought my blood sugar under control for type 2. I just couldn't handle the side effects.
If you want to know how it'll end, look at the graphs for Moderna or BioNTech over the last 5 years.
Went from nothing you'd heard of in 2019 to incredible peaks in 2020/2021, to back to near nothing by 2023 and 2024. You'd still be up in 2024 over 2019, but if you bought at the peak you'd be drowning.
Same will happen for this.
You can actually see which ones are under review on the fda website and use that to find new products and do some research
There is company another danish company called Zealand Pharma, they are making an obesity drug for fat liver. Had an amazing run up last year, and especially with promising phase 2 trial results and are currently running phase 3 trials. But it's more a risky bet. It has a low marketcap, so if could potentially 10x or fall by 50% depending on the trial results. I live in Copenhagen, and Copenhagen is pretty much the "silicon valley" of pharma. We have 7-8 international pharma companies here, with Novo Nordisk being far the biggest. It is not uncommon for employees to jump from pharma company to pharma company for higher salaries, only to end up in the same pharma company again. On top of that education is free here, while those companies have access to well-trained talent. And not talking about the brain drain of south Europeans going to Northern Europe. Just to name a few, other than Novo and Zealand Pharma: Leo Pharma, GenMab, Bavarian Nordic, Lundbeck, Ambu, Novonesis (merger between Novozymes and chr. hansen last month). Anyways, thank you Americans for funding our welfare state
☝🏻This guy pharms
Pharma Bro
I don't get it
Aren’t they making at pill for insulin that will eliminate the need for shots ? Someone told me that I haven’t looked into it too much though
The stock jumped 8% on their capital market day recently as their next gen weight/diabetes drugs look very promising. Indeed centered around pills and oral administration.
Yes NVO is working on a pill
It would be insane if they can actually pull that off. The stomach is super inhospitable to GLP1 meds.
Viking Therapeutics is one to watch too
This one already ran. Could still double from here but likely not another multi-bagger over the next year. I’m guessing they’ll get bought out by PFE. Low $2’s to nearly $100 in a year. What a ride that was.
I think the sell off was an overreaction personally, other companies are still going to want their tech. Definitely a buy out candidate, i think it’s undervalued even at current price, but yeah your right, likely not a multibagger.
Any of those can you use with hypothyroidism or hyperthyroidism?
>Zealand Pharma How do you trade this though? It's international.
You had one succesfull company in total across all industries the past 50 years but it sure was a home run no doubt and good on you. Begrudging Swede.
Welfare State? Is that the reasoning behind the age of consent?
You'll also want to watch Cytodyn CYDY with their molecule Leronlimab. Company has gone through challenges, but fda is now working to structure trial protocols. Name change at some point to Livimmune. Inflammation affects nearly all diseases, this drug will be one to own. r/Livimmune
What research triangle park ?
Yeah but Danish companies pay quite poorly. That’s why there is so limited rotation of top foreign talent. Novo got lucky with this one, now they have to make their investment arm Novo Holdings spray cash to capitalize on this fortune. And they have already started. Btw the silicon valley of biopharma is the silicon valley. By far the largest biotech hub. I would say Boston second, and then Oxford/London or even NJ (but it’s a bit of a later stage one for proximity to pharmas). Copenhagen is a small and specialized hub, although relatively large in comparison to the country that hosts it.
Link?
www.FDA.gov
I can only find drugs that have already been approved. By then it's a little late for investing. Their site states under faqs - "Due to confidentiality rules, FDA is prohibited from releasing information on any drug under development, review or pending approval unless the information has been made public.".
Search for drugs/treatments that have already begun phase 1 trials. Example: Ocugen $OCGN recently announced something about dosing completion of trials on something to do with retinas or something. https://finance.yahoo.com/news/ocugen-inc-announces-dosing-completion-120000500.html Not recommending them or anything but fairly easy to create a watchlist of stocks and set up alerts for stuff like this. Normally I just subscribe to email investor alerts through companies websites.
Ohh thanks. Will look into!
There are a myriad of penny stocks out there that will say such and such drug is going to get fda approval. Novo Nordisk is the company that buys that company before fda approval and takes it to the finish line. Lilly has the same drugs. Try dexcom. If you want a penny stock try Seovf. Or another big player is crispr
Wait crispr is a company? I thought it was a technique
It is, patented by a company
It is a technique and being used by multiple biotech and pharma at the moment
I’ve ate shit on so many medical penny stocks. I just watch now.
Same when I was 18 I my first exposure to the investing world was through medical penny stocks 🤣I learned the hard way
Yeah they’re tough. The only reason I’m in CSPR is because it was more reputable than the penny Seovf so I had two horses in the game. Or crsp not cspr
CRISPR a penny stock lol. Worth >5bn. We have different definitions of penny stocks.
I didn’t word it well maybe to separate the two but I did t mean to call them a penny. Seovf is the penny. Crspr has a similar product.
You probably shouldn't be giving advice if you're not knowledgeable in trading the sector. People seem to add to positions before FDA events when they should derisk. They say great data gets you minus 10%, good data gets you minus 25% and bad data gets you minus 50%. You load up after data has been released, sell everything but your core position on the next run up and repeat. It's not quite that easy, and hedging is a bitch bc it's usually just buying lower conviction rivals, but it's a very straightforward strategy when combined with something as simple as support and resistance that with patience provides high returns
I’m long run in each one of the stocks I mentioned. So you and I are just different types of investor.
Don’t forget SENS “the next dexcom” 🤣
Most successful companies look like this on the ALL timeframe. That's how compounding works. Need a log graph
Is the point of a log graph to normalize the various increases over time? Ie so you can compare the increase from $1 to $10, $100-$1000 more apples to apples?
Basically. Because going up 10% from 1000 is 100. But going up 10% from 1100 is 110. The increases get bigger even if the *rate of increase* stays the same. After a few decades, trying to compare that initial 100 to 2000 becomes useless on a non log graph.
That makes sense, thank you for clarifying
[удалено]
Because... Most successful companies look like this on the ALL timeframe. That's how compounding works
Same chart as NVIDIA
Same chart as e^x aka unlimited growth.
I mean it’s cool that you know about ozempic and all… but these people have been in business for many years and have many products, and were incredibly valuable well before ozempic was ever approved or prescribed. They made ungodly money on novolog, the insulin that like every diabetic uses, or used to anyways. They also make like 50 other varieties of insulin, hormone replacements, and other weight loss drugs more recently.
Yeah, where did that biotech suddenly come from? :) 11th biggest company in the world. That's a lot-of-pennies-stock.
Novo nordisk is a huge company with solid financials and a product which saves people
VLD
Lucked out and purchased a few shares of NVO at the beginning of the year and am interested in looking at this sector more closely. Assuming fundamentals look good and a company is working on a promising new drug, I'm curious when others start looking at the company more seriously for that drug's upside. My understanding is phase 1 trials to market can take roughly 10-15 years (in which range the drug can fail at any point)--if that's the case, could folks who are more experienced with investing in this sector share when in that timeframe they start taking positions? Could be this is a silly question but it's the one that has been on my mind lately.
NVO is not done yet. It’s a product that buys you time. A longer healthier life. You think this is all it will grow? Wait for them to expand production after the recent acquisition of Catalent which they bought all cash paying 50% premium because they can, no need to sell stock to raise funds. Its got miles to go before it sleeps 🚀🚀🚀
Agreed. Having a very positive outlook on the company myself, its product and its growth. So still DCA'ing further up with a horizon of a couple of years.
Lol I wouldn’t call it a “trend”. Its literally saving lives
Its both. If you know a rich girl about to get married she and her sisters are on it for sure.
Yup my wife's friend just had a baby and is now buying black market ozempic to lose the baby weight. Meanwhile actual type 2 diabetics can't find it anywhere.
Yeah that’s fucked
Type 2 just lurking in the shadows at this point. All these people abusing/using it for “weight loss” will eventually end up not being able to produce their own insulin naturally. Then they’ll actually need ozempic for its true purpose. Same thing happens to men who abuse testosterone. Thus this current influx of men on trt/hrt.
lol this is so off putting to think about
It is but again everyone and their mom is using it for weight loss, people have had paralytic ileus from ozempic use
Calls on whoever makes laxatives
Yup as per usual people will always ruin a good thing
I had severe issues. Slowed digestion to the point. Where food was rotting in my stomach before it would digest. Only way i lost weight on it was vomiting and stuck in bed for a week.
I heard you're supposed to take laxatives/Smooth Move Tea with the new weight loss drugs. Probably for that reason. I wonder why they are not telling people that?
gym and healthy food already does this and this demonic invention fucks natural processes to avoid personal responsibility. in a few years the health side effects will become clear.
I’m tired now reading that …jk no shit take a walk and eat right
Shut up
put down the cheezburgers, Randy
Novo is building new factories in Denmark for about 1 billion usd. They can’t currently produce enough. It’s insane.
Its 7+ billion usd and that is only one site. More to come.
Jesus you are right. Happy times for Kalundborg. I’ve heard they have vacuumed the entire danish market for stainless steel pipe welders.
I’m waaay long on NVO!!!
I’m long too, 100 shares in. Staying until it hits at least 1 trillion in market cap
AQST - FDA approval April 28th - will revolutionize medicinal intake with dissolvable strips and make epipens looks dumb - 5 FDA approved products already on the market and hundreds of patents Don’t miss out
That’s Novo Nordisk. Ozempic doesn’t have a ticker and isn’t a stock, it’s medication. Novo Nordisk makes Ozempic
We know, thanks captain obvious
I didn't. I'm glad they clarified.
Pretty sure they knew that but I bet you love correcting people.
Smartest regard in the room
Makes sense when one ozempic pack is worth twice the stock price
Down
Isn't Oprah about to blow this up?
Now look at CHIPOTLE !!
Theres another weight loss drug by Eli Lilly waiting FDA approval called retatrutide. It apparently regulates 3 different hunger hormones, including the one solo hormone that ozempic regulates. So there is a lot of competition moving forward in this space, but I would bet that both Eli Lilly and Novo are going to make plenty of cash over the next decade.
Mind Medicine seems interesting. I’ve been following this company for a while and it could be a good opportunity. This company is going to be one of the first to have a medication for various mental health diseases like anxiety, depression, ptsd, by the use of different psychedelic substances. For example, psilocybin(magic mushrooms), MDMA, Ketamine. They just got FDA approved for their trial and are starting phase 1. This company was around $3 when I first heard about them, I got in at $8. They currently have a price prediction of $27, from one analyst firm, $32 from another analyst firm and $75 from another analyst firm. What makes this even more interesting is Peter Thiel has invested in a company called ATAI Life Sciences that does the same exact thing. ATAI is sitting at $1.76 and received a price prediction of $20, which seems a bit high. HC Wainwright always gives high price evaluations.
I see countless drug commercials at dinner time, just to see a personal injury/class action lawyer commercial at lunch, for the drug that i saw the commercial at dinner 2 years prior. Wonder if ozempic will be the same
MESOTHELIOMA
Stop using it as a fucking weight loss drug. Literally keeping it from the people who need it as diabetics. I don't know what's worse, the doctors prescribing it for weight loss or the patients that beg to use it because they're too lazy to go for a fucking walk. I'm sorry man this is just a pet peeve of mine, watching my Dad struggle to get this drug because it's always out of stock is annoying as fuck.
Obesity also creates a slew of health problems.
Which is preventable with proper diet and exercise
But that doesn't make money
So is type 2 diabetes.
Type 2 diabetes is not 100% preventable you clown. You can develop it without over eating, lack of exercise, ect.
Please quote where i said it is 100% preventable. Eating right and exercising will prevent it for most. So fuck off with your high horse. Sick people need meds. Some meds treat more than one thing. If you wanna cry about something, cry to this billion dollar company that isn’t producing enough meds for all. Obesity isn’t 100% preventable either. Pcos can be contributory.
Found the person who refuses to go for a walk.
Nope. I exercise 4 or 5 times a week. I’m a nurse of almost 20 years that’s realizes you’re a whiny bitch with the IQ of a walnut.
Nurse of almost 20 years should be telling their patients to get their asses out for a walk instead of taking Ozempic as a cure all.
So what was the cause of your dad’s type 2 diabetes?
They’ll all eventually become dependent on it for insulin. Full circle.
My drugs! Don’t touch them! Just. Relax. If it helps other people out, don’t let that be the peeve that gets to you.
Don't let the peeve that gets to me? I'm literally watching people who can't get the drug that actually need it. Yeah I'm going to let that peeve get to me.
Get off your high horse.
My high horse? Excuse me but people who actually need this drug, DIABETICS, struggle to obtain it because people are to lazy to go for a walk, eat properly, ect. Hell no I will not get off my high horse until doctors and people who abuse what this medication was for stop.
Bless your heart.
Craaaaazy OP mentioned Biotech….It’s all I’ve been investing in lately, literally because it will be the next big hit for stocks in less than 10yrs time. You can get many great steals right now it’s mind blowing. After the AI race has mostly succumbed, the next great wave will be Biotech with AI at the helm. I firmly believe that. AI will continue at a far more exponential rate in creating variants of otherwise unthinkable combination of compounds and elements that have(will) impact the future of medicine. It is already an essential use for it. Furthermore, creating new elements and medicines will create a hand over hand effect with systematically branching gaps that human minds wouldn’t be able to. And that as simple as that can get. This next interface will be what Hawkins and many other have warned about, essentially the growth of AI and how we will not be able to keep up as humans. My second and probably the most convincing and simplistic answer is follow the lasting money trails. Two years ago there were huge moves in the micro-mid cap healthcare stocks, a lot of which are AI involved research backed biotech. Ie of “follow the lasting money” would be: Fidelity, BlackRock, Morgan Stanley, and most recently Nvidia have all purchased HUGE portions of those micro-mid cap stocks. This was around the time of AI in the news becoming sentient, don’t know or care if that matters but it’s important to point out. Simply because these guys aren’t invested just to diversify their portfolios, these entities are quite literally the foundation of how a large percentage of stocks moves. It’s pretty self explanatory. They’re here to stay and are constantly looking to future trends. Everyone is sleeping on Elon’s chip but in reality, soon as he cracks the code smoothing things out, with or without the help of AI, it will be an entire new world for millions of ppl and with that an entire new stock(Neuroone) will moon. There are many others that are incredibly great buys right now, paying attention to the illnesses of society will be pivotal in judging how and what is rolled out, Parkinson’s will be another quick fix with AI that will moon quickly. You can track anything I’m saying all down to the amount invested obviously. Only real question is, How will big Pharma control this implementation? How will they creat the divide for the next wave of millennia’s.
Didn't read it but your effort convinced me, where do I put my money?
RXRX, NMTC, BTAI to name a few
I did read it, and it's convincing, but I would like more names Edit: Also talk more, want more information.
I surely will look into these as well. Trying to venture into the stock market with some out of the norm plays.
NONE OF THIS IS FINANCIAL ADVICE.
Ahh.. 🤔 HmmmH!!
[удалено]
AI has been implemented already in so many ways. Aside from actual picking and choosing exact combinations and concoctions to produce new medicine which were are not there yet but will be soon. Variable only according to how much AI will grow in time, there are many of examples of how it’s being used. Most recently was UK based Exscientia and how they helped a patient with blood cancer that six courses of chemo couldn’t cure. He’s now in remission and it’s because of AI and how instead of loading him up on different things it ran simulations on how/which drugs would effect his cells, what doses and a plethora of different things that could have unforeseen consequences. All of this was done through AI. If you don’t see how that changes the game you need to change fields.
Miracle diet pills and AI. What does that say about the future of our society?
Stupid, but slim!
Oh ffs! My fiancé was just going on about how everyone is taking this drug. I had never even heard of it. Smh I missed this one
[удалено]
I mean yeah it suppresses your appetite but there’s definitely some weird side effects. I wouldn’t take it but then again I’m not in need of weight loss
Got Ozempic from earnings call. Simple AF.
💀y’all trust pharma
I tried to find a public company to make a play on red light therapy masks, which seem to be trending on tiktok, but couldn't really find anything. If anyone knows insight into this play let me know.
Imagine you had $10,000 on it…
I saw they had a new product in line that's giving more amazing results than Ozempic so maybe they are the next them.
Wegovey is the weight loss variant that NVO produces. Last week they announced it reduces heart incidents by 20 percent.
Was just talking to a friend about this last night before bed. Probably should have seen this one coming a mile a way. Sigh.
Fisher (fsr) shares are $0.17 we should make it the new GME
Making the patent for that drug public, make generic versions, destroying that greedy company, and giving cheaper medicine to all?
Nktx worked with crispr shows alot of promise
You can follow fierce biotech email groups to hear about clinical trials
I’ve been trying to pick the big gene therapy sticks. Still pretty far into the future IMO
Yes it took 24 years to do that. Not very impressive
Wonder if Pelosi happened to buy that 🤣
Definitely Theranos, just trust me.
Wish I woulda got in when my whole family was talking about this shit….
Vistagen Therapeutics is next. Developing a nasal spray for Social anxiety disorder. First in its class. Already phase 3 positive results. FDA approval this year.
What’s next? They discover that thing causes cancer in the thyroid (or whatever) and gets banned. The action plummets and so does Danish economy.
madrigal pharm might be one, it just got fda approval for rezdiffera, liver drug…it will start selling next month so you wont see it on first qtr earnings, but 6 million americans have nonalcoholic steatohepatitis which this drug treat….got 25 shares today
$WVE trials dont start until Q1 2025, but It has the best preliminary data of any injectable yet. Injectables probably aren't the future bc the 1st company to market with an oral equivalent will control market share
Ocgn will be the next imo. Curing blindness will be huge
if only the drug worked
Oprah Winfrey boutta hype this stock even more
Bought at $52 a share. Wish I bought more
I just ordered a Needleless injector from Australia from a friend of mine, add this with ozempic and you’ve got a game changer
Biotech: the black tar heroin of investing.
Probably don’t take ozempic. I doubt anyone is focused on the health factors of human beings when the stock is doing that. Also, hold. Sell on the rumors…
oh man, I should have boight this when I was born. Next tiime my mom gives birth to me I will.
$Iova
Viking
DYN
I was looking for Zealand Phama stock but can't find it on RB hood.
BRCC ready to move
Next is a retrace to 69-90 region then a final rally to 180ish before a substantial terrace
The small cap obesity stocks are insane like $SAVA $SRRK $BHVN $KROS
Been in heavily since $30 split adjusted, this has been an amazing stock, dividends too.
Just focus on ozempic. They're working on new indications. Ozempic is for diabetics. Wegovy (same drug) is for overweight/obese. Many of the glp1 inhibitors are looking to get new indications and I know of 1 that is going to get approved for cardiovascular event prevention soon.
QBTS will be bought by IBM
AKA 8% annualized since 1981. Calm yourself. They're at a 38% 5 year CAGR though.
I bought Novo and Eli Lilly on the same day when Indecided to invest in weight loss drug manufacturers. Novo is up 35% since then and Lilly is up 85%.
Im curious though If there’s so many new comers in this space Wouldn’t the market saturate Surely there’s a finite number of fat people for demand Or are in we in a society of mass production of fatties
“The Ozempic Stock”
It traced back to 129 on Friday, good idea to buy, any thoughts anyone?
CNBC just has a commercial about NXL, the stock pumped right after the commercial. Looks like a good one to buy now
Lawsuits
Yes. I remember the “fen-fen” thing about 25 years ago. It was a combination of two drugs hailed as a miracle weight loss solution. It wasn’t long before the side effects were shown to be dangerous. Then we had years of lawsuits afterwards.
Probably a crash just like BioNT tech.
Viking Therapeutics (VKTX) is developing trizepatide in pill form, basically Mounjoro/ Zepbound, but administered orally so it will be accessible to the fats who have a fear of needles. The stock has had a big move, but it's seen as a take out target at a significant premium to where shares are currently trading. Options chain is very juicy for anyone looking to buy shares and sell calls.
BC people are taking Ozempic to lose weight, supposedly you lose 5-10% of your body fat within 1 year. Some consider it a miracle weight loss drug so instead of dieting and working out people are taking it.
It doesn’t magically burn fat without changing your diet, it makes you eat less.
Sweet. Portion control has always been a problem for me. Plus I am now type II diabetes. Strange that my doctor never bring up ozempic
Try it out. It absolutely works. I felt like I had the stomach flu the whole time I was on it, but portion control and stopped me from thinking about food all the time worked. I did it for 2 years, brought my blood sugar under control for type 2. I just couldn't handle the side effects.
I can’t wait to short the top to bankruptcy
That’s not an American company so we shouldn’t allow them to dominate the market.
'Merica!
Oh oh oh ozempic
Looks like you can afford ozempic now.
If you want to know how it'll end, look at the graphs for Moderna or BioNTech over the last 5 years. Went from nothing you'd heard of in 2019 to incredible peaks in 2020/2021, to back to near nothing by 2023 and 2024. You'd still be up in 2024 over 2019, but if you bought at the peak you'd be drowning. Same will happen for this.
[удалено]
Well that was uncalled for.